Celyad Oncology S.A.
Celyad Oncology S.A.（CLYYF）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
clyyf · 股价预测 · 4 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 4 位华尔街分析师
Buy
4 位分析师
共识
评级分布
12 个月目标价
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $0.25
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.25 | ↓ 0.60% |
1-day model range: $0.25–$0.25. Peak: $0.25 (-0.60%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · CLYYF · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2022-01-10 | Wells Fargo | Maintains | Overweight→Overweight |
| 2021-08-05 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2021-05-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2021-03-25 | JonesTrading | Downgrade ↓ | Buy→Hold |
| 2020-12-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2020-03-25 | Wells Fargo | Maintains | Overweight→Overweight |
| 2020-03-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2016-07-04 | UBS | Downgrade ↓ | Buy→Neutral |
| 2015-08-25 | UBS | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Celyad Oncology S.A. (CLYYF) stock. Of the recent 9 rating actions, 0 were upgrades and 2 were downgrades. 4 analysts currently cover CLYYF.
分析师推荐趋势
CLYYF analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↓ 99.4% YoY
Revenue Next Year
$2M
↑ 24474.7% YoY
EPS This Year
$-2.26
EPS Next Year
$-2.20
↓ 2.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast CLYYF EPS of $-2.26 for the current fiscal year, based on estimates from 1 analysts. The CLYYF revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CLYYF 股价预测由两类独立数据源支撑：来自 4 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CLYYF 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。
CLYYF 的短期预测（明日）为 $0.25（-0.60%）。
Celyad Oncology S.A. 在 OTC 上市，代码 CLYYF。CLYYF 在 2027 年的整体展望偏积极，在覆盖分析师中约 50% 对应 Buy 共识。
常见问题
CLYYF 预测 · 8 个问题根据 4 位华尔街分析师，CLYYF 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $0.25，隐含约 +0.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.